Teva and the approval of the migraine drug Ajovy®

Teva announced the FDA approval of their migraine drug Ajovy┬« (Fremanezumab) – a mAB CGRP inhibitor – in a press release on September 21st. I felt it would be a good time to revisit Teva and migraine drugs, since a lot of things have happened, since their largest ever acquisition of Actavis Generics from Allergan …